1-amino-1,3-dicarboxycyclopentane and Hypercalcemia

1-amino-1,3-dicarboxycyclopentane has been researched along with Hypercalcemia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beka, TI; Boas, DA; Chen, J; Cheng, Q; Cui, J; Dale, AM; Devor, A; Einevoll, GT; Gratiy, SL; MacDonald, CL; Masliah, E; Nizar, K; Reznichenko, L; Saisan, PA; Sakadzić, S; Silva, GA; Sridhar, VB; Steed, TC; Tian, P; Uhlirova, H; Weldy, KL1

Other Studies

1 other study(ies) available for 1-amino-1,3-dicarboxycyclopentane and Hypercalcemia

ArticleYear
In vivo stimulus-induced vasodilation occurs without IP3 receptor activation and may precede astrocytic calcium increase.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2013, May-08, Volume: 33, Issue:19

    Topics: Action Potentials; Adenosine Triphosphate; Animals; Astrocytes; Calcium; Cycloleucine; Dextrans; Egtazic Acid; Electric Stimulation; Female; Fluorescein-5-isothiocyanate; Hypercalcemia; Inositol 1,4,5-Trisphosphate Receptors; Male; Mice; Mice, Inbred ICR; Mice, Knockout; Neurons; Neuroprotective Agents; Signal Transduction; Time Factors; Vasodilation

2013